Point of Care Testing in Haematology

References

• Marks, V. (1985). The trend towards decentralisation: lessons from history. In: Clinical Biochemistry Nearer the Patient (Eds.) Marks, V. and Alberti, K. G. M. M., London: Churchill Livingstone, pp. 1–4.
   Google Scholar
• Felder, R. A. (1996). Robotic automation of near-patient testing. In: Handbook of Clinical Automation, Robotics, and Optimization, (Eds.) Kost, G. J., Wiley and Sons, pp. 596–619.
   Google Scholar
• Hilton, S. (1990). Near patient testing in general practice: a review. Br. J. Gen. Pract., 40, 32–36.
   PubMed Web of Science ®Google Scholar
• Hobbs, F. D. R., Delaney, B. C., Fitzmaurice, D. A. et al. (1997). A review of near patient testing in primary care. Appendix 3. Health Technol. Assessment, 1(5), 169–219.
   Google Scholar
• van den Berg, A. and Bergveld, P. (1995). Micro Total Analysis Systems, Kluwer Academic Publishers, p. 311.
   Google Scholar
• Gibb, I. (1986). Pre- and post-analytical considerations in near-patient analysis. In: Clinical Biochemistry Nearer the Patient II, (Eds.) Marks, V. and Alberti, K. G. M. M., London: Bailliere Tindall, pp. 103–113.
   Google Scholar
• Tsai, W. W., Nash, D. B., Seamonds, B. and Weir, G. J. (1994). Point-of-care versus central laboratory testing: an economic analysis in an Academic Medical Center. Clin. Therapeut., 16, 898–910.
   PubMed Web of Science ®Google Scholar
• Zipp, A. and Hornby, W. E. (1984). Solid-phase chemistry: its principles and applications in clinical analysis. Talanta, 31, 863–877.
   PubMedGoogle Scholar
• Steinhausen, R. L. and Price, C. P. (1985). Principles and practice of dry chemistry systems. In: Recent Advances in Clinical Biochemistry, (Eds.) by Price, C. P. and Alberti, K. G. M. M., London: Churchill Livingstone, pp. 273–296.
   Google Scholar
• Hillyard, C. J., Blake, A. S., Wilson, K. et al. (1987). A latex agglutination assay for D-dimer: evaluation and application to the diagnosis of thrombotic disease. Clin. Chem., 33, 1837–1840.
   PubMed Web of Science ®Google Scholar
• John, M. A., Elms, M. J., O'Reilly, E. J. et al. (1990). The Simplired D dimer test: a novel assay for the detection of crosslinked fibrin degradation products in whole blood. Thromb. Res., 58, 273–281.
   PubMed Web of Science ®Google Scholar
• Coller, B. S., Lang, D. and Scudder, L. E. (1997). Rapid and simple platelet function assay to assess glycoprotein llb/llla receptor blockade. Circulation, 95, 860–867.
   PubMed Web of Science ®Google Scholar
• Spayd, R. W., Bruschi, B., Burdick, B. A. et al. (1978). Multilayer-film elements for clinical analysis: application to representative chemical determinations. Clin. Chem., 24, 1343–1350.
   PubMed Web of Science ®Google Scholar
• Price, C. P. and Roller, P. U. (1988). A multicentre study of the new Reflotron system for the measurement of urea, glucose, triacylglycerols, cholesterol, gamma-glutamyltransferase and haemoglobin. J. Clin. Chem. Clin. Biochem., 26, 233–250.
   PubMedGoogle Scholar
• Reich, D. L. (1991). Monitoring hemostasis in the perioperative period: anticoagulation control. J. Cardio-thorac. Vasc. Anesth., 5, 4–7.
   PubMedGoogle Scholar
• Blumenthal, R. S., Carter, S. J., Resar, J. E. et al. (1995). Comparison of bedside and hospital laboratory coagulation studies during and after coronary intervention. Cath. and Cardiovasc. Diag., 35, 9–17.
   PubMedGoogle Scholar
• Avendaño, A. and Ferguson, J. J. (1994). Comparison of Hemochron and HemoTec activated coagulation time target values during percutaneous transluminal coronary angioplasty. J. Am. Coll. Cardiol., 23, 907–910.
   PubMed Web of Science ®Google Scholar
• Pan, C.-M., Jobes, D., Van Riper, D. et al. (1996). Modified microsample ACT test for heparin monitoring. J. Extra-corporeal Technol., 28, 16–20.
   Google Scholar
• Performance evaluation of the ProTime™ Microcoagulation System (1997). Prepared and distributed by International Technidyne Corporation Educational Services.
   Google Scholar
• Lucas, F. V., Duncan, A., Jay, R. et al. (1987). A novel whole blood capillary technic for measuring the prothrombin time. Am. J. Clin. Pathol., 88, 442–446.
   PubMed Web of Science ®Google Scholar
• Machin, S. J., Mackie, I. J., Chitolie, A. and Lawrie, A. S. (1996). Near patient testing (NPT) in haemostasis—a synoptic view. Clin. Lab. Haem., 18, 69–74.
   PubMedGoogle Scholar
• Oberhardt, B. J., Dermott, S. C., Taylor, M. et al. (1991). Dry reagent technology for rapid, convenient measurements of blood coagulation and fibrinolysis. Clin. Chem., 37, 520–526.
   PubMed Web of Science ®Google Scholar
• van den Besselaar, A. M. H. P., Breddin, K., Lutze, G. et al. (1995). Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coag. Fibrin., 6, 726–732.
   PubMed Web of Science ®Google Scholar
• Spiess, B. D. and Ivankovich, A. D. (1988). Thromboelastography: A coagulation-monitoring technique applied to cardiopulmonary bypass. In: Effective Hemostasis in Cardiac Surgery, (Eds.) Ellison N. and Jobe D. R. Philadelphia: P. A. Saunders, pp. 163–181.
   Google Scholar
• Despotis, G. J., Levine, V., Filos, K. S. et al. (1996). Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology, 85, 1311–1323.
   PubMed Web of Science ®Google Scholar
• Kundu, S. K., Heilmann, E. J., Sio, R. et al. (1995). Description of an in vitro platelet function analyzer—PFA-100™. Seminars in Thrombosis and Hemostatis, 21, 106–112.
   PubMed Web of Science ®Google Scholar
• Despotis, G. J., Alsoufiev, A. and Hogue, C. W. et al. (1996). Evaluation of complete blood count results from a new, on-site hemocytometer compared with a laboratory-based hemocytometer. Crit. Care Med., 24, 1163–1167.
   PubMed Web of Science ®Google Scholar
• Becker, D. M., Humphries, J. E., Walker, F. B. et al. (1993). Standardizing the prothrombin time: calibration coagulation instruments as well as thromboplastin. Arch. Pathol. Lab. Med., 117, 602–605.
   PubMed Web of Science ®Google Scholar
• Despotis, G. J., Summerfield, A. L., Joist, J. H. et al. (1994). In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients. Anesth. Analg., 79, 670–674.
   PubMed Web of Science ®Google Scholar
• Macik, B. G. (1995). Designing a point-of-care program for coagulation testing. Arch. Pathol. Lab. Med., 119, 929–938.
   PubMed Web of Science ®Google Scholar
• Van den Besselaar, A. M. H. P., Evatt, B. L., Brogan, D. R. and Triplett, D. A. (1984). Proficiency testing and standardization of prothormbin time: Effect of thromboplastin, instrumentation, and plasma. Am. J. Clin. Pathol., 82, 688–699.
   PubMed Web of Science ®Google Scholar
• Van Dijk-Wierda, C. A., Van Halam-Viser, L. P., Van der Hoaff-Van Halem, R. and Loeliger, E. A. (1978). The preparation of control blood for external quality assessment programmes in oral anticoagulant control. Thrombosis and Haemostasis, 39, 210–214.
   PubMed Web of Science ®Google Scholar
• Burnett, D. and Freedman, D. (1994). Near-patient testing: the management issues. Health Services Management, March, pp. 10–13.
   Google Scholar
• Association of Clinical Biochemists (1993). Guidelines for implementation of near-patient testing. Available from Royal Society of Chemistry, Burlington House, Piccadilly, London W1V 0BN.
   Google Scholar
• Joint Working Group (JWG) on External Quality Assessment (EQA) in Pathology (1992). Guide-lines on the control of near-patient tests (NPT) and procedures performed on patients by non-pathology staff. Available from D. Kilshaw, Secretary, JWGEQA, c/o Mast House, Derby Road, Liverpool L20 1EA.
   Google Scholar
• England, J. M., Hyde, K., Lewis, S. M. et al. (1995). Guide-lines for near patient testing: haematology. Clin. Lab. Haem., 17, 301–310.
   PubMedGoogle Scholar
• Green, M. (1995). Successful alternatives to alternate site testing. Use of a pneumatic tube system to the central laboratory. Arch. Pathol. Lab. Med., 119, 943–947.
   PubMed Web of Science ®Google Scholar
• Naghibi, F., Han, Y., Dodds, W. J. and Lawrence, C. E. (1988). Effects of reagent and instrument on prothrombin time, activated partial thromboplastin times and patient/control ratios. Thromb. Haemostas., 59, 455–465.
   PubMed Web of Science ®Google Scholar
• Despotis, G. J., Santoro, S. A., Spitznagel, E. et al. (1994). On-site prothrombin time, activated partial thromboplastin time, and platelet count. Anesthesiology, 80, 338–351.
   PubMed Web of Science ®Google Scholar
• Jennings, I., Luddington, R. J. and Baglin, T. (1991). Evaluation of the Ciba Corning Biotrack 512 coagulation monitor for the control of oral anticoagulation. J. Clin. Pathol., 44, 950–953.
   PubMed Web of Science ®Google Scholar
• Price, C. P. (1986). Quality assurance of extra-laboratory analyses. In: Clinical Biochemistry Nearer the Patient II, (Eds.) Marks, V. and Alberti, K. G. M. M. London: Bailliere Tindall, pp. 166–178.
   Google Scholar
• Burrin, J. M., Williams, D. R. R. and Price, C. P. (1985). Performance of a quality assessment scheme for blood glucose meters in general practice. Ann. Clin. Biochem., 22, 148–151.
   PubMed Web of Science ®Google Scholar
• De Cresce, R. P., Phillips, D. L. and Howanitz, P. J. (1995). Financial justification of alternate site testing. Arch. Pathol. Lab. Med., 119, 898–901.
   PubMed Web of Science ®Google Scholar
• Chernow, B. (1993). Blood conservation in critical care—the evidence accumulates. Crit. Care Med., 21, 481–482.
   PubMed Web of Science ®Google Scholar
• Spiess, B. D., Gillies, B. S., Chandler, W. and Verrier, E. (1995). Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J. Cardiothorac. Vasc. Anesth., 9, 168–173.
   PubMed Web of Science ®Google Scholar
• Gelb, A. B., Roth, R. I., Levin, J. et al. (1996). Changes in blood coagulation during and following cardiopulmonary bypass. Am. J. Clin. Pathol., 106, 87–99.
   PubMed Web of Science ®Google Scholar
• Jobes, D. R., Schaffer, G. W. and Aitken, G. L. (1995). Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J. Thorac. Cardiovasc. Surg., 110, 36–45.
   PubMed Web of Science ®Google Scholar
• Despotis, G. J., Joist, J. H., Hogue, C. W. et al. (1995). The impact of heparin concentration and activated clotting time monitoring on blood conservation: a prospective, randomized evaluation in patients undergoing cardiac operations. J. Thorac. Cardiovasc. Surg., 110, 46–54.
   PubMed Web of Science ®Google Scholar
• Verska, J. J. (1977). Control of heparinization of activated clotting time during bypass with improved postoperative hemostasis. Ann. Thorac. Surg., 24, 170–173.
   PubMed Web of Science ®Google Scholar
• Guffin, A. V., Dunbar, R. W., Kaplan, J. A. and Bland, J. W. Jr. (1976). Sucessful use of a reduced dose of protamine after cardiopulmonary bypass. Anesth. Analg., 55, 110–113.
   PubMed Web of Science ®Google Scholar
• Despotis, G. J., Santoro, S. A., Spitznagel, E. et al. (1994). Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J. Thorac Cardiovasc. Surg., 107, 271–279.
   PubMed Web of Science ®Google Scholar
• Despotis, G. J., Grishaber, J. E. and Goodnough, L. T. (1994). The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion, 34, 290–296.
   PubMed Web of Science ®Google Scholar
• Becker, R. C., Cyr, J., Corrao, J. M. and Ball, S. P. (1994). Bedside coagulation monitoring in heparin-treated patients with active thromboembolic disease: a coronary care unit experience. Am. Heart J., 128, 719–723.
   PubMed Web of Science ®Google Scholar
• Nuttall, G. A., Oliver, W. C., Beynen, F. M. et al. (1993). Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass. J. Cardio. Vas. Anesthes., 7, 402–409.
   PubMedGoogle Scholar
• Greilich, P. E., Carr, M. E. Jr., Carr, S. L. and Chang, A. S. (1995). Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth. Analg., 80, 459–465.
   PubMed Web of Science ®Google Scholar
• Kang, Y. G., Martin, D. J., Marquez, J. et al. (1985). Intraoperative changes in blood coagulation and thromboelastographic monitoring in liver transplantation. Anesth. Analg., 64, 888–896.
   PubMed Web of Science ®Google Scholar
• Sane, D. C., Gresalfi, N. J., Enney-O'Mara, L. A. et al. (1992). Exploration of rapid bedside monitoring of coagulation and fibrinolysis parameters during thrombolytic therapy. Blood Coagul. Fibrinolysis, 3, 47–54.
   PubMed Web of Science ®Google Scholar
• Dorman, B. H., Spinale, F. G., Bailey, M. K. et al. (1993). Identification of patients at risk for excessive blood loss during coronary artery bypass surgery: thromboelastography versus coagulation screen. Anesth. Analg., 76, 694–700.
   PubMed Web of Science ®Google Scholar
• Ginsberg, J. S., Wells, P. S., Brill-Edwards, P. et al. (1995). Application of a novel and rapid whole blood assay for D-dimer in patients with clinically suspected pulmonary embolism. Thrombo. Haemostas., 73, 35–38.
   PubMed Web of Science ®Google Scholar
• Wells, P. S., Brill-Edwards, P., Stevens, P. et al. (1995). A novel and rapid whole-blood assay for D-dimer in patients with clinically suspected deep vein thrombosis. Circulation, 91, 2184–2187.
   PubMed Web of Science ®Google Scholar
• Rose, V. L., Dermott, S. C., Murray, B. F. et al. (1993). Decentralized testing for prothrombin time and activated partial thromboplastic time using a dry chemistry portable analyzer. Arch. Pathol. Lab. Med., 117, 611–617.
   PubMed Web of Science ®Google Scholar
• Macgregor, S. H., Hamley, J. G., Dunbar, J. A. et al. (1996). Evaluation of a primary care anticoagulant clinic managed by a pharmacist. Br. Med. J., 312, 560.
   PubMedGoogle Scholar
• Hall, J. and Radley, A. S. (1994). A role for community pharmacists in the control of anticoagulant therapy. Pharm. J., 252, 230–232.
   Google Scholar
• White, R. H., McCurdy, S. A., von Marensdorff, H. et al. (1989). Home prothrombin time monitoring after the initiation of warfarin therapy. Ann. Intern. Med., 111, 730–737.
   PubMed Web of Science ®Google Scholar
• Ansell, J., Holden, A. and Knapic, N. (1989). Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times. Arch. Intern. Med., 149, 2509–2511.
   PubMedGoogle Scholar
• Fitzmaurice, D. A., Hobbs, F. D. R., Murray, E. T. and Gilbert Rose, P. E. (1995). A randomised controlled trial comparing primary care oral anticoagulant management utilising computerised decision support (DSS) and near patient testing (NPT) with traditional management. Fam. Pract., 12, 253–254.
   Google Scholar
• Despotis, G. J., Joist, J. H. and Goodnough, L. T. (1997). Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin. Chem., 43, 1684–1696.
   PubMed Web of Science ®Google Scholar